Stock Comparison
ABT vs SYK
Abbott Laboratories and Stryker Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$163.94B
$127.55B
P/E (TTM)
26.4
38.5
Forward P/E
17.2
22.2
Price/Sales
3.6
5.1
Price/Book
3.2
5.6
EV/EBITDA
16.1
21.6
Dividend Yield
2.62%
1.09%
Profitability
Net Margin
13.90%
13.20%
Operating Margin
13.50%
17.80%
Return on Equity
12.30%
15.20%
Return on Assets
5.59%
7.72%
Growth (YoY)
Revenue Growth
7.80%
2.60%
Earnings Growth
-19.70%
14.20%
Price & Risk
Beta
0.6
0.8
52-Week High
$135.34
$401.86
52-Week Low
$81.97
$281.00
Analyst Target
$116.54
$386.80
Compare ABT and SYK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.